- Multi Species
- Use - Measure Allopregnanolone in 2.5 Hours
- Sample - Extracted Serum, Plasma, Fecal, and Urine or TCM
- Samples/Kit - 38 or 230 in Duplicate
- Selective - Low Cross Reactivity to Progesterone and Metabolites
Our Allopregnanolone Immunoassay Kit (K044-H) will be discontinued on October 1, 2019. This kit is being replaced with our Allopregnanolone EIA Kit, Monoclonal Antibody Based (K061-H) which is now available.
The DetectX® Allopregnanolone Immunoassay kit is designed to quantitatively measure Allopregnanolone present in extracted serum, plasma, and dried fecal samples, and in urine and tissue culture media samples. An allopregnanolone standard is provided to generate a standard curve for the assay and all samples should be read off the standard curve. Standards or diluted samples are pipetted into a clear microtiter plate coated with an antibody to capture rabbit antibodies. An allopregnanolone-peroxidase conjugate is added to the wells. The binding reaction for the EIA/ELISA is initiated by the addition of a polyclonal antibody to allopregnanolone to each well. After incubation the plate is washed and substrate is added. The substrate reacts with the bound allopregnanolone-peroxidase conjugate. After a short incubation, the reaction is stopped and the intensity of the generated color from the EIA/ELISA is detected in a microtiter plate reader capable of measuring 450nm wavelength.
Allopregnanolone aids neurogenesis and has been found to reverse neuron proliferative deficit and cognitive deficits in a mouse model of Alzheimer’s disease. Allopregnanolone has also been shown to restore functionality in a mouse model of Parkinson’s Disease. It has also been shown to improve behavioral problems in post-traumatic stress disorder.